Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Survival of motor neuron 2 (SMN2) is a gene that encodes the survival motor neuron (SMN) protein, which is essential for motor neuron maintenance and function. SMN2 primarily produces a truncated, non-functional protein due to exon 7 skipping. However, a small percentage of transcripts produce full-length SMN protein, and increased SMN2 copy number can partially compensate for the loss of SMN1 function in spinal muscular atrophy. Therefore, it is a therapeutic target.
Therapeutics target increased expression or correct splicing from existing SMN2-derived transcripts
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Survival of Motor Neuron 2 (SMN2).